FILE:WAT/WAT-8K-20020708154012.txt.gz
EVENTS:	Other events	Financial statements and exhibits
TEXT:
ITEM: Other events
ITEM: Financial statements and exhibits
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported) July 8, 2002 Waters Corporation ------------------------------------------------------ (Exact Name of Registrant as Specified in Its Charter) Delaware ---------------------------------------------- (State or Other Jurisdiction of Incorporation) 01-14010 13-3668640 ------------------------ --------------------------------- (Commission File Number) (IRS Employer Identification No.) 34 Maple Street, Milford, Massachusetts 01757 - ---------------------------------------- ---------- (Address of Principal Executive Offices) (Zip Code) (508) 478-2000 ---------------------------------------------------- (Registrant's Telephone Number, Including Area Code) N/A ------------------------------------------------------------- (Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events The purpose of this Form 8-K is to inform the public and security holders of a press release announcing the Company's field integration of the Micromass division with the Waters division. A copy of the press release is attached as Exhibit 99.1. Certain statements contained in the current report on Form 8-K are forward-looking. These statements are subject to various risks and uncertainties, many of which are outside the control of the Registrant, including (i) changes in the HPLC, mass spectrometry and thermal analysis portions of the analytical instrument marketplace as a result of economic or regulatory influences, (ii) changes in the competitive marketplace, including new products or pricing changes by the Registrant's competitors, and (iii) the ability of the Registrant to generate increased sales and profitability from new product introductions, as well as additional risk factors set forth in the Registrant's Form 10-K for its fiscal year ended December 31, 2001. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements the Registrant may make, whether because of these factors or for other reasons. The Registrant does not assume any obligations to update any forward-looking statement that it makes. Item 7. Financial Statements and Exhibits (C) Exhibit 99.1 Press Release dated July 8, 2002
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WATERS CORPORATION Dated: July 8, 2002 By: /s/ John Ornell ------------------------------- Name: John Ornell Title: Vice President, Finance and Administration and Chief Financial Officer

Exhibit 99.1 For Immediate Release: Contact: Waters Corporation Gene Cassis 508-482-2349 Waters Corporation Announces Field Integration Milford, Massachusetts, July 8, 2002 - Waters Corporation (NYSE: WAT) announced today that it is fully integrating the worldwide sales, service and distributor groups of the Micromass division with the Waters division. By creating a unified distribution channel between the two groups, Waters will be able to leverage the strengths of both its MS and HPLC divisions. "This new strategy allows us to present a single face and a total solution to customers anywhere in the world and will align and position the field organization to more rapidly respond to the quickly evolving needs of our LC/MS customers. We already have the broadest range of HPLC and MS products available in the world and this integration will allow us to fully leverage our potential," said Arthur Caputo, President of Waters Business Operations. Waters Corporation has worldwide leading positions in three complementary analytical technologies - high performance liquid chromatography (HPLC), mass spectrometry and thermal analysis - which account for $4.2 billion in annual revenues of the $19 billion analytical instrument market.


